Cargando…
Escitalopram Personalized Dosing: A Population Pharmacokinetics Repository Method
Escitalopram (SCIT) represents a first-line antidepressant and antianxiety medication. Pharmacokinetic studies of SCIT have demonstrated considerable interindividual variability, emphasizing the need for personalized dosing. Accordingly, we aimed to create a repository of parametric population pharm...
Autores principales: | Liu, Xin, Ju, Gehang, Yang, Wenyu, Chen, Lulu, Xu, Nuo, He, Qingfeng, Zhu, Xiao, Ouyang, Dongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544162/ https://www.ncbi.nlm.nih.gov/pubmed/37789969 http://dx.doi.org/10.2147/DDDT.S425654 |
Ejemplares similares
-
Establishment and Evaluation of a Parametric Population Pharmacokinetic Model Repository for Ganciclovir and Valganciclovir
por: Yang, Wenyu, et al.
Publicado: (2023) -
CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population
por: Huang, Xinyi, et al.
Publicado: (2021) -
Population pharmacokinetics model for escitalopram in Chinese psychiatric patients: effect of CYP2C19 and age
por: Liu, Shujing, et al.
Publicado: (2022) -
Unilateral Galactorrhea Associated with Low-dose Escitalopram
por: Ravi, P. Bangalore, et al.
Publicado: (2014) -
The effect of a single dose of escitalopram on sensorimotor networks
por: Weisstanner, Christian, et al.
Publicado: (2018)